补中升清泻阴火复方联合胰岛素治疗2型糖尿病临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R587.1

基金项目:

浙江中医药科技计划(2018ZA053);浙江中医药大学校级科研项目(2017ZY15)


Clinical Study on Buzhong Shengqing Xieyinhuo Compound Prescription Combined with Insulin for Type 2 Diabetes Mellitus
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察补中升清泻阴火复方联合胰岛素对2型糖尿病患者胰岛β细胞功能及糖脂代谢的影响。方法:将100 例2 型糖尿病患者随机分为治疗组50例,采用补中升清泻阴火复方联合预混胰岛素治疗;对照组50例,采用安慰剂联合预混胰岛素治疗。比较2组治疗前后胰岛素、C肽、胰岛素敏感指数(IAI),胰岛素抵抗指数(HOMA-IR) 和胰岛素分泌指数(HOMA-β)等胰岛功能情况的变化,血糖水平、糖化血红蛋白(HbA1c) 等糖代谢水平的变化,以及甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C) 等脂代谢指标的变化及低血糖发生率情况。结果:治疗后,治疗组空腹血糖(FPG)、餐后2h血糖(P2hBG) 均明显更低,治疗组FPG 达标率和P2hBG 达标率则明显升高,低血糖比降低,差异均有统计学意义(P<0.05)。治疗后,治疗组空腹腹胰岛素(FINS)、IAI、HOMA-β 高于对照组(P<0.05),治疗组HOMA-IR 指数与对照组比较,差异无统计学意义(P>0.05)。治疗后,治疗组HbA1c、TG、LDL-C均低于对照组(P<0.05)。治疗后,2组中医证候积分均比治疗前明显下降,差异均有统计学意义(P<0.05),治疗组积分下降程度比对照组更明显(P<0.05)。结论:2型糖尿病患者加用补中升清泻阴火复方治疗有助于患者胰岛β细胞功能的恢复,稳定2型糖尿病患者血糖水平,改善患者机体脂质代谢紊乱状态,且减少低血糖的风险。

    Abstract:

    Abstract: Objective: To observe the effect of Buzhong Shengqing Xieyinhuo compound prescription combined with insulin on islet β-cell function and glucose and lipid metabolism in patients with type 2 diabetes mellitus. Methods:A total of 100 cases of patients with type 2 diabetes mellitus were randomly divided into the treatment group and the control group,50 cases in each group. The treatment group was given Buzhong Shengqing Xieyinhuo compound prescription combined with premixed insulin,and the control group was given placebo combined with premixed insulin. Before and after treatment,the changes in islet function including insulin, C- peptide, Insulin Acuity Index(IAI), the index of Homeostatic Model Assessment of Insulin Resistance(HOMA- IR), as well as the index of Homeostatic Model Assessment for β cell function (HOMA-β),the changes in the levels of glucose metabolism including blood glucose level and glycosylated hemoglobin A1c (HbA1c), the changes in the indexes of lipid metabolism including triglyceride(TG) and low density lipoprotein- cholesterol (LDL-C),as well as the incidence of hypoglycemia were compared between the two groups. Results:After treatment,in the treatment group, the levels of fasting glucose(FPG) and 2- hour postprandial blood glucose(PPG) were significantly lower, the standard- reaching rates of FPG and PPG were significantly higher, and the proportion of hypoglycemia was lower,differences being significant(P<0.05). After treatment,the levels of fasting insulin(FINS),IAI and HOMA- β in the treatment group were higher than those in the control group(P<0.05),and there was no significant difference being found in the comparison of the index of HOMA-IR between the two groups(P>0.05). After treatment,in the treatment group,the levels of HbA1c,TG and LDL-C were lower than those in the control group(P<0.05). After treatment,the Chinese medicine syndrome scores in the two groups were significantly decreased when compared with those before treatment,differences being significant(P<0.05),and the decrease of the scores in the treatment group was more significant than that in the control group(P<0.05). Conclusion: The additional therapy of Buzhong Shengqing Xieyinhuo compound prescription in treating patients with type 2 diabetes mellitus,can conduce the recovery of islet β-cell function,stabilize the levels of blood glucose level,improve the disturbance state of lipid metabolism in body ,as well as reduce the risk of hypoglycemia.

    参考文献
    相似文献
    引证文献
引用本文

王进波,邹玉婷,李能娟,胡江.补中升清泻阴火复方联合胰岛素治疗2型糖尿病临床研究[J].新中医,2020,52(12):79-82

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-06-15
  • 出版日期:
文章二维码